We have located links that may give you full text access.
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Peer review in a small and a big medical journal: case study of the Croatian Medical Journal and the Lancet.
Croatian Medical Journal 2002 June
AIM: To compare reviewers recommendations and editorial decisions in The Lancet, a high-impact journal, and Croatian Medical Journal (CMJ), a small general medical journal.
METHOD: Case study of research manuscripts submitted to the CMJ (n=140 manuscripts; 308 review forms) and a sample of similar manuscripts submitted to The Lancet (n=141; 348 review forms) in 1999 and the first half of 2000. Reviewers recommendations and their influence on editorial decisions on manuscripts were analyzed by logistic regression. Agreement between reviewers was assessed by the kappa statistic.
RESULTS: Although reviewers scores were identical in the two journals (median=3 for both journals, range 0 to 5), Lancet reviewers more often recommended rejection than CMJ reviewers (44% vs 17%; chi-square=52.1, p=0.029), and agreed best on rejection (kappa=0.29 [95% CI=0.04 to 0.53] vs kappa=-0.04 [-0.45 to 0.36] for CMJ). Lancet editors were even stricter than their reviewers and accepted for publication only 53% [95% CI=37 to 68] of manuscripts graded acceptable by the reviewers, compared with 85% [73 to 91] for CMJ editors (chi-square=10.0, p=0.001). For nine questions about manuscript quality in the review form, multiple regression analysis showed significant association between editorial decision and reviewers scores for the suitability of research design (B=0.70, OR=2.01, 95% CI=1.40 to 2.89, p<0.001) and discussion of systematic/random error (B=0.32, OR=1.38 [1.03 to 1.85], p=0.031) for The Lancet, and scores for novelty of information (B=0.56, OR=1.75 [1.35 to 2.27], p<0.001) for the CMJ.
CONCLUSION: Reviewers of big journals, such as The Lancet, are stricter in their recommendations reviewers of a smaller journal, such as the CMJ. The Lancet editors rely on reviewers to identify methodologically superior studies, whereas CMJ editors look for the novelty of information in a manuscript.
METHOD: Case study of research manuscripts submitted to the CMJ (n=140 manuscripts; 308 review forms) and a sample of similar manuscripts submitted to The Lancet (n=141; 348 review forms) in 1999 and the first half of 2000. Reviewers recommendations and their influence on editorial decisions on manuscripts were analyzed by logistic regression. Agreement between reviewers was assessed by the kappa statistic.
RESULTS: Although reviewers scores were identical in the two journals (median=3 for both journals, range 0 to 5), Lancet reviewers more often recommended rejection than CMJ reviewers (44% vs 17%; chi-square=52.1, p=0.029), and agreed best on rejection (kappa=0.29 [95% CI=0.04 to 0.53] vs kappa=-0.04 [-0.45 to 0.36] for CMJ). Lancet editors were even stricter than their reviewers and accepted for publication only 53% [95% CI=37 to 68] of manuscripts graded acceptable by the reviewers, compared with 85% [73 to 91] for CMJ editors (chi-square=10.0, p=0.001). For nine questions about manuscript quality in the review form, multiple regression analysis showed significant association between editorial decision and reviewers scores for the suitability of research design (B=0.70, OR=2.01, 95% CI=1.40 to 2.89, p<0.001) and discussion of systematic/random error (B=0.32, OR=1.38 [1.03 to 1.85], p=0.031) for The Lancet, and scores for novelty of information (B=0.56, OR=1.75 [1.35 to 2.27], p<0.001) for the CMJ.
CONCLUSION: Reviewers of big journals, such as The Lancet, are stricter in their recommendations reviewers of a smaller journal, such as the CMJ. The Lancet editors rely on reviewers to identify methodologically superior studies, whereas CMJ editors look for the novelty of information in a manuscript.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app